CohBar Inc (COB.U):企業の財務・戦略的SWOT分析

◆英語タイトル:CohBar Inc (COB.U) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH466903FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CohBar Inc (CohBar) is a developer of mitochondria based therapeutics. The company develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, type 2 diabetes, cancer, cardiovascular disease and CNS disorders. It offers MDP drugs such as MOTS-c for regulation of metabolism and therapeutic potential for diabetes mellitus, obesity, fatty liver and cancers; SHLP-6 for cancer; humanin against Alzheimer’s disease, atherosclerosis, myocardial and cerebral ischemia and diabetes; and SHLP-2 for Alzheimer’s disease. CohBar’s expertise comprises cellular and mitochondrial genetics and biology, metabolism, the biology of aging, drug discovery, development and commercialization. The company also conducts scientific research in the fields of age-related diseases, mitochondrial genomics and biology, longevity, metabolism and MDP’s. CohBar is headquartered in Menlo Park, California, the US.

CohBar Inc Key Recent Developments

Mar 30,2021: CohBar Reports Fourth Quarter 2020 Financial Results and Provides Business Update
Mar 29,2021: CohBar Completes Enrollment in the Phase 1b Clinical Trial for CB4211 Under Development for NASH and Obesity
Mar 16,2021: CohBar to Announce 2020 Fourth Quarter Financial Results and Provide Business Update on March 30, 2021
Mar 12,2021: CohBar to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
Mar 02,2021: CohBar to Present at the 33rd Annual ROTH Conference

This comprehensive SWOT profile of CohBar Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of CohBar Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

CohBar Inc – Key Information
CohBar Inc – Overview
CohBar Inc – Key Employees
CohBar Inc – Key Employee Biographies
CohBar Inc – Key Operational Heads
CohBar Inc – Major Products and Services
CohBar Inc – History
CohBar Inc – Company Statement
CohBar Inc – Locations And Subsidiaries
CohBar Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

CohBar Inc – Business Description
CohBar Inc – Corporate Strategy
CohBar Inc – SWOT Analysis
SWOT Analysis – Overview
CohBar Inc – Strengths
CohBar Inc – Weaknesses
CohBar Inc – Opportunities
CohBar Inc – Threats
CohBar Inc – Key Competitors

Section 3 – Company Financial Performance Charts

CohBar Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

CohBar Inc, Key Information
CohBar Inc, Key Ratios
CohBar Inc, Share Data
CohBar Inc, Major Products and Services
CohBar Inc, History
CohBar Inc, Key Employees
CohBar Inc, Key Employee Biographies
CohBar Inc, Key Operational Heads
CohBar Inc, Other Locations
CohBar Inc, Subsidiaries
CohBar Inc, Key Competitors
CohBar Inc, SWOT Analysis
CohBar Inc, Ratios based on current share price
CohBar Inc, Annual Ratios
CohBar Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[CohBar Inc (COB.U):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Magna International Inc.:企業の戦略・SWOT・財務情報
    Magna International Inc. - Strategy, SWOT and Corporate Finance Report Summary Magna International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Mistras Group Inc (MG):企業の財務・戦略的SWOT分析
    Summary Mistras Group Inc (Mistras) is a provider of technology-enabled asset protection solutions that offers used to evaluate the structural integrity of critical energy, industrial and public infrastructure. The company provides products such as acoustic emission, ultrasonic, and vibration and Pd …
  • Petra Energy Berhad (PENERGY):石油・ガス:M&Aディール及び事業提携情報
    Summary Petra Energy Berhad (Petra Energy) is an integrated brown field service provider for the upstream oil and gas industry. The company offers services such as designing, procurement, engineering, installation, fabrication, commissioning, maintenance, construction and project management. It also …
  • Trevena Inc (TRVN):企業の財務・戦略的SWOT分析
    Summary Trevena Inc (Trevena) is a biotechnology company that discovers and develops G-protein coupled receptor targeted medicines. The company provides products such as RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination w …
  • Netflix Inc.:企業の戦略・SWOT・財務分析
    Netflix Inc. - Strategy, SWOT and Corporate Finance Report Summary Netflix Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Milagen Inc:企業の製品パイプライン分析
    Summary Milagen Inc (Milagen) is a medical device company. It provides diagnostic products. The company generates antibody reagents against the human proteome. It discovers, develops and markets non invasive immunodiagnostic products for monitoring, surveillance and detection of cancers. Milagen off …
  • PerkinElmer, Inc.:企業の戦略・SWOT・財務情報
    PerkinElmer, Inc. - Strategy, SWOT and Corporate Finance Report Summary PerkinElmer, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mochida Pharmaceutical Co Ltd (4534):製薬・医療:M&Aディール及び事業提携情報
    Summary Mochida Pharmaceutical Co Ltd (Mochida) is a pharmaceutical company that develops, manufactures and markets drugs and diagnostic regents. The company's drugs are used for the treatment of arteriosclerosis obliterans, hyperlipidemia, hypertension, angina pectoris, endometriosis, mycosis, thro …
  • Pharma Mar SA (PHM)-製薬・医療分野:企業M&A・提携分析
    Summary Pharma Mar SA (Pharma Mar) is a biopharmaceutical company that discovers, develops and markets marine-derived drugs to treat cancer. The company’s marketed product Yondelis (trabectedin), a novel, multimodal, synthetically produced antitumor agent, is indicated for the treatment of advanced …
  • Farmer Bros. Co. (FARM):企業の財務・戦略的SWOT分析
    Farmer Bros. Co. (FARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • DTEK Energy B.V.:電力:M&Aディール及び事業提携情報
    Summary DTEK Energy B.V. (DTEK Energy), formerly DTEK Holdings B.V., is a vertically-integrated utility that conducts coal mining and processing; electricity generation; manufacture of mining machinery; trading of coal and electricity in Ukrainian and international markets; and repair and maintenanc …
  • Kadimastem Ltd (KDST):企業の財務・戦略的SWOT分析
    Summary Kadimastem Ltd (Kadimastem) is a clinical stage biopharmaceutical company that develops industrial regenerative medicines to treat neuro-degenerative diseases. Its technology platform enables the manufacturing of islet-like endocrine cells (differentiated cells) and glia restricted progenito …
  • Altius Minerals Corp:企業の戦略・SWOT・財務分析
    Altius Minerals Corp - Strategy, SWOT and Corporate Finance Report Summary Altius Minerals Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Life Time Inc:企業の戦略的SWOT分析
    Life Time Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Tribal Group Plc (TRB):企業の財務・戦略的SWOT分析
    Tribal Group Plc (TRB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • HemaCare Corp (HEMA)-医療機器分野:企業M&A・提携分析
    Summary HemaCare Corp (HemaCare) is a provider of biological blood products and services. The company offers primary blood cells and tissues derived from normal and mobilized peripheral blood, bone marrow and cord blood. It spans its expertise in isolations, custom cell collections and testing of pr …
  • CropEnergies AG (CE2):企業の財務・戦略的SWOT分析
    CropEnergies AG (CE2) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Powszechny Zaklad Ubezpieczen Group:戦略・SWOT・企業財務分析
    Powszechny Zaklad Ubezpieczen Group - Strategy, SWOT and Corporate Finance Report Summary Powszechny Zaklad Ubezpieczen Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • American Electric Power Company, Inc.:企業の戦略・SWOT・財務分析
    American Electric Power Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Electric Power Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Omega Diagnostics Group Plc (ODX):医療機器:M&Aディール及び事業提携情報
    Summary Omega Diagnostics Group Plc (Omega) is a biotechnology company that provides in-vitro diagnostic products. The company provides products in the areas of allergy, food intolerance, autoimmune disease and infectious disease, among others. It also provides food intolerance and autoimmune tests …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆